Dean Mula

Dean has worked for over 12 years in the life sciences industry. Recently, Dean led the Controllership functions of both AskBio, which was sold to Bayer AG in December 2020, and Precision BioSciences, which completed a $146M IPO in 2019. Prior to that, Dean worked in corporate finance for MedImmune, Cisco Systems, 3Com, and HP. He began his career as a CPA and holds degrees from Babson College and Bentley University.